PITTSBURGH--(BUSINESS WIRE)--Helomics (formerly Precision Therapeutics), a privately held comprehensive personalized healthcare company that develops innovative next generation diagnostics for the oncology field, announced today that it will be recognized as a recipient of the 2014 Pittsburgh Smart 50 Awards, presented by Chase and Smart Business. President and CEO Neil Campbell will accept the award on behalf of Helomics at the awards ceremony on Nov. 19 at the Marriott Pittsburgh City Center.
Help employers find you! Check out all the jobs and post your resume.
